C12N 2710/14011
Baculoviridae
C12N2710/14011 (Baculoviridae) appears on 694 US grants and 792 published applications in this corpus.
Search patents in C12N- Granted patents
- 694
- Published applications
- 792
- Assignees
- 484
- Inventors
- 1,672
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 8 | 0 |
| 1992 | 12 | 0 |
| 1993 | 12 | 0 |
| 1994 | 14 | 0 |
| 1995 | 11 | 0 |
| 1996 | 11 | 0 |
| 1997 | 25 | 0 |
| 1998 | 32 | 0 |
| 1999 | 34 | 0 |
| 2000 | 21 | 0 |
| 2001 | 33 | 1 |
| 2002 | 20 | 21 |
| 2003 | 14 | 19 |
| 2004 | 19 | 39 |
| 2005 | 12 | 32 |
| 2006 | 18 | 26 |
| 2007 | 18 | 24 |
| 2008 | 19 | 32 |
| 2009 | 14 | 43 |
| 2010 | 16 | 42 |
| 2011 | 23 | 34 |
| 2012 | 11 | 29 |
| 2013 | 17 | 30 |
| 2014 | 18 | 24 |
| 2015 | 24 | 42 |
| 2016 | 20 | 24 |
| 2017 | 23 | 30 |
| 2018 | 31 | 30 |
| 2019 | 29 | 31 |
| 2020 | 26 | 39 |
| 2021 | 15 | 38 |
| 2022 | 21 | 37 |
| 2023 | 14 | 30 |
| 2024 | 17 | 43 |
| 2025 | 18 | 32 |
| 2026 | 16 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/14111NucleopolyhedrovirusIndexing code562
- C12N 2710/14041Use of virus, viral particle or viral elements as a vectorIndexing code176
- C12N 2710/14051Methods of production or purification of viral materialIndexing code31
- C12N 2710/14021Viruses as suchIndexing code15
- C12N 2710/14022New viral proteins or individual genes, new structural or functional aspects ofIndexing code12
- C12N 2710/14034Use of virus or viral component as vaccineIndexing code9
- C12N 2710/14023Virus like particles [vlp]Indexing code5
- C12N 2710/14031Uses of virus other than therapeutic or vaccineIndexing code5
All 13 subgroupsShow fewer
- C12N 2710/14032Use of virus as therapeutic agent, other than vaccineIndexing code3
- C12N 2710/14061Methods of inactivation or attenuationIndexing code3
- C12N 2710/14033Use of viral protein as therapeutic agent other than vaccineIndexing code2
- C12N 2710/14071Demonstrated in vivo effectIndexing code1
- C12N 2710/14088For redistributionIndexing code0
Recent patents
- Recombinant adeno-associated virus compositions and methods for producing same8 Sep 2026US 12,729,385 B2Prevail Therapeutics, Inc.
- Baculovirus expression vector4 Aug 2026US 12,697,381 B2Intervet Inc.
- Baculovirus expression system28 Jul 2026US 12,692,481 B2Virovek, Inc.
- Method of producing an immunogenic composition7 Jul 2026US 12,673,094 B2Boehringer Ingelheim Animal Health USA Inc.
- DNA impurities in a composition comprising a parvoviral virion7 Jul 2026US 12,674,211 B2uniQure IP B.V.
- Engineered tet enzymes and use in epigenetics and next generation sequencing (ngs), such as tet-assisted pyridine borane sequencing (taps)1 Oct 2026US 2026/0297543 A1Exact Sciences Innovation LTD.
- Generation of adeno-associated virus capsid libraries for insect cells10 Sep 2026US 2026/0265729 A1uniQure biopharma B.V.
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Gene therapies for lysosomal disorders27 Aug 2026US 2026/0250715 A1Prevail Therapeutics, Inc.
- Fusion protein of ge and gi of varicella-zoster virus and use6 Aug 2026US 2026/0224694 A1
Most cited
By later US patents
- Insect control agent288US 6,326,193 B1Cambria Biosciences, LLC · 2001
- Method for producing a recombinant baculovirus expression vector209US 4,745,051 AThe Texas A&M University System · 1988
- Baculovirus expression system and method for high throughput expression of genetic material170US 6,225,060 B1Onyx Pharmaceuticals, Inc. · 2001
- Method for producing a recombinant baculovirus expression vector164US 4,879,236 AThe Texas A&M University System · 1989
- Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein146US 5,858,368 AProtein Sciences Corporation · 1999